NexGel (NXGL) vs Profusa (PFSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Profusa is the larger company by market cap ($868,861 vs $82,806), about 10.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NXGL | PFSA |
|---|---|---|
| Share price | $0.1699 | $1.43 |
| Market cap | $82.81K | $868.86K |
| 1-day change | +13.27% | -3.72% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-14.80 | $897.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $57.00 | $3,000.00 |
| 52-week low | $0.151 | $1.40 |
| Distance from 52-week high | -99.70% | -99.95% |
| Analyst consensus | hold | — |
| Average volume | 37.86K | 2.74M |
| Shares outstanding | 487.38K | 605.65K |
| Employees | 19 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Profusa is about 10.5 times larger than NexGel by market value ($868.86K vs $82.81K).
About NexGel
NXGL stock →NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Health Care · Medical/Dental Instruments · 19 employees
About Profusa
PFSA stock →Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
Health Care · Medical/Dental Instruments
NXGL vs PFSA FAQ
Which is bigger, NexGel or Profusa?
Profusa (PFSA) is larger, with a market capitalization of $868.86K compared with $82.81K for NexGel (NXGL).
Are NexGel and Profusa in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.